Edgewater Ranzal’s Tony Scalese Publishes “The Definitive Guide to Oracle FDMEE”
Feb 23, 2016 13:30 pm UTC| Business
WHITE PLAINS, N.Y., Feb. 23, 2016 -- Edgewater Technology-Ranzal, LLC, (Edgewater Ranzal), a wholly-owned subsidiary of Edgewater Technology, Inc. (NASDAQ:EDGW) and Platinum level member of Oracle Partner Network (OPN),...
Feb 23, 2016 13:30 pm UTC| Business
NEWARK, N.J., Feb. 23, 2016 -- Neurotrope, Inc. (NTRP), a clinical-stage company developing a disruptive therapy for the treatment of severe Alzheimer’s disease (AD), today announced that Dr. Daniel Alkon, Neurotrope’s...
Gordagen to Trial New Drug Delivery Technology From Monash University
Feb 23, 2016 13:30 pm UTC| Business
MELBOURNE, Australia, Feb. 23, 2016 -- Gordagen Pharmaceuticals, an Australian nutraceutical and pharmaceutical company, is pleased to announce a collaborative research agreement with Monash University to assess a new...
Amyris to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on Wednesday, March 9, 2016
Feb 23, 2016 13:30 pm UTC| Business
EMERYVILLE, Calif., Feb. 23, 2016 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2015 after market close on Wednesday, March 9, 2016. The Company...
GWG Holdings to Report Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 13:30 pm UTC| Business
MINNEAPOLIS, Feb. 23, 2016 -- GWG Holdings, Inc. (NASDAQ:GWGH) (“GWG” or “the Company”), a specialty finance company and a leader in the life insurance secondary market, announced it will release fourth quarter and full...
Feb 23, 2016 13:29 pm UTC| Business
SAN FRANCISCO, Feb. 23, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm with offices in Phoenix, Arizona, reminds Insys Therapeutics Inc. (NASDAQ:INSY) investors of April 4, 2016 lead...
Feb 23, 2016 13:12 pm UTC| Business
CAMBRIDGE, Mass., Feb. 23, 2016 -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), aPhase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate, lasmiditan, for the acute treatment of...